Search
Sanofi SA
SNYAdd to Watchlist
43.160USD
+1.530+3.68%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
103.60BMarket Cap
12.00P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-02The current earnings forecast score of Sanofi SA is 7.60, ranking 97 out of 157 in the Pharmaceuticals industry. The average price target is 58.58, with a high of 74.67 and a low of 56.00.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
57.105
Target Price
+32.31%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Sanofi SA
SNY
10
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
Vertex Pharmaceuticals Inc
VRTX
34
AbbVie Inc
ABBV
33
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Sanofi SA's expected revenue for the next quarter?
Sanofi SA's expected revenue is 12.70B.
What is Sanofi SA's price target?
Analysts forecast that Sanofi SA's price target is USD 58.58, with the highest forecast at USD 74.67 and the lowest forecast at USD 56.00.
How have Sanofi SASNY's recent earnings per share performed?
The market expectation was USD 0.78, while Sanofi SASNY's earnings per share (EPS) for the previous quarter was USD -0.38. EPS for the next quarter is expected at USD 1.14.
What is the analyst rating for Sanofi SA?
Based on the ratings of Sanofi SA's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.